Clinical development of neridronate: potential for new applications
Davide Gatti, Maurizio Rossini, Ombretta Viapiana, Luca Idolazzi, Silvano AdamiRheumatology Unit, Department of Medicine, University of Verona, Verona, ItalyAbstract: Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget's diseas...
Saved in:
Main Authors: | Gatti D (Author), Rossini M (Author), Viapiana O (Author), Idolazzi L (Author), Adami S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of mandible Paget's disease of the bone treated with intravenous neridronate
by: A. Fassio, et al.
Published: (2016) -
Vitamin D and fractures: a sistematic review
by: L. Idolazzi, et al.
Published: (2011) -
Improvements in the management of rheumatic patients from vertebral image obtained through dual-energy X-ray absorptiometry
by: D. Gatti, et al.
Published: (2011) -
Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013) -
Vitamin D and rheumatic diseases
by: M. Rossini, et al.
Published: (2014)